CDKN2A and lung cancer: Given the high prevalence of K-ras and p16 gene deficiencies in human lung cancers [33]–[36], we evaluated for K-ras gene mutations and p16 promoter methylation in the spontaneous lung cancers in both transgenic and non-transgenic animals.